Sentences with phrase «lobular carcinoma»

Ultrasound was found to be inferior for detecting axillary node metastasis in patients with invasive lobular carcinoma compared with invasive ductal carcinoma.

Lobular carcinoma in situ, or LCIS, is not a cancer, but an overgrowth of cells that occurs in the milk - producing lobules.

Selected characteristics of controls, invasive ductal carcinoma cases, and invasive lobular carcinoma cases

Also known as «infiltrating lobular carcinoma,» ILC can spread beyond the lobules into surrounding breast tissue and metastasize to other parts of the body.

Therefore, women with invasive lobular carcinoma may benefit from axillary biopsies regardless of the appearance of the nodes on ultrasoiund

When Jennifer Bolstad was pregnant, she developed stage 0 lobular carcinoma in situ in the small amount of breast tissue that she had remaining on the «healthy» side.

Methods: We combined data from two population - based case - control studies to examine the relationship between migraine and risk of postmenopausal invasive breast cancer among 1,199 ductal carcinoma cases, 739 lobular carcinoma cases, and 1,474 controls 55 to 79 years of age.

Breast cancer may also begin in the glandular tissue called lobules (invasive lobular carcinoma) or in other cells or tissue within the breast.

Ductal breast cancer, which is in the ducts that carry milk, is the most common type of breast cancer and lobular carcinoma, which begins in the milk - producing glands, is the second most common.

Invasive lobular carcinoma is a cancer that starts in the lobules, an area of the breast where milk is produced.

Pleomorphic invasive lobular carcinoma is a unique subset of lobular breast cancer that has abnormally aggressive tumor cells and results in poorer outcomes than the classic lobular breast cancer.

Breast Cancer — Breast cancer in young women (ages 18 - 45), pregnancy - associated breast cancer, ductal carcinoma in situ, lobular carcinoma in situ, invasive ductal carcinoma, invasive lobular carcinoma

PELOPS: Palbociclib and Endocrine Therapy for Lobular Breast Cancer Preoperative Study: A Randomized Phase II Study of Palbociclib with Endocrine Therapy versus Endocrine Therapy Alone for Invasive Lobular Carcinoma and Invasive Ductal Carcinoma

Dr. Jos Jonkers» research group studies the genetic basis of human breast cancer, using advanced mouse models for p53 - induced breast cancer, BRCA1 - and BRCA2 - associated hereditary breast cancer, and E-cadherin mutated invasive lobular carcinoma.

Invasive lobular carcinoma, or ILC, is an uncommon type of breast cancer that begins in the milk - producing lobule cells and invades (spreads) deeper into the breast tissue.

But when her doctor told her that the type of tumor she had — invasive lobular carcinoma — slightly increased her risk of developing cancer in the unaffected breast, she decided to have a double mastectomy and sacrifice her ability to breast - feed.

Women are generally in this group if they have multiple cases of breast or ovarian cancer in the family, a positive result on the BRCA breast cancer gene - mutation test, a personal history of the disease, or a biopsy showing atypia or lobular carcinoma in situ.

It is also important to note that inflammatory breast cancer is much more aggressive than the other types of invasive breast cancers we have discussed, including both invasive ductal carcinoma and invasive lobular carcinoma.

Most breast cancers originate in the milk ducts or lobes and are called ductal carcinoma or lobular carcinoma, respectively.

While ductal carcinoma in situ develops in the duct's lining of the breasts, lobular carcinoma in situ develops in the lobules — the parts of the breast tissue that is responsible for the production of milk.

Prime examples are ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS).

Common types of breast cancer include ductal carcinoma (the cells that line the milk ducts) and lobular carcinoma (the cells found in breast lobules).

Breast Cancer — Breast cancer in young women (ages 18 - 45), pregnancy - associated breast cancer, ductal carcinoma in situ, lobular carcinoma in situ, invasive ductal carcinoma, invasive lobular carcinoma

Results: Women who reported a clinical diagnosis of migraine had reduced risks of ductal carcinoma (OR, 0.67; 95 % CI, 0.54 - 0.82) and lobular carcinoma (OR, 0.68; 95 % CI, 0.52 - 0.90).